[ Price : $8.95]
A new analysis from investment firm Jefferies finds that nearly three-quarters of drug candidates that received an FDA breakthroug...[ Price : $8.95]
FDA clears a Methinks AI 510(k) for its Methinks CTA Stroke, an artificial intelligencebased software tool that detects suspected ...[ Price : $8.95]
CBER director Vinay Prasad orchestrates leadership changes at the Center, appointing several new acting deputy directors and reass...[ Price : $8.95]
The D.C. federal court says FDA correctly approved labeling for MSNs generic form of Novartis Entresto.[ Price : $8.95]
FDA warns Lutz, FL-based New Life Medical Services that it is illegally marketing unapproved human cells, tissues, and cellular an...[ Price : $8.95]
Age Reversal Unity petitions FDA to create a new regulatory pathway to cover so-called enhanced drugs to fight aging as a disease.[ Price : $8.95]
Complement Therapeutics gains IND clearance to begin human testing of its lead gene therapy, CTx001, in patients with geographic a...[ Price : $8.95]
FDA grants Vivace Therapeutics a fast track designation for its lead cancer drug VT3989, a first-in-class TEAD autopalmitoylation ...